LOCALLY ADVANCED/METASTATIC SOLID TUMORS
Clinical trials for LOCALLY ADVANCED/METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED/METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED/METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug ISM3412 enters first human tests for hard-to-treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called ISM3412 in about 80 adults whose advanced solid tumors have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants must have a specific geneti…
Matched conditions: LOCALLY ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
New drug ESG406 enters human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called ESG406 in adults with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and to see if the drug can shrink tumors. About 556 participants will take part in this …
Matched conditions: LOCALLY ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Shanghai Escugen Biotechnology Co., Ltd • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
New hope for advanced tumors? experimental drug CR-001 enters human testing
Disease control Recruiting nowThis study tests a new drug, CR-001, in adults with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find the safest dose and see if the drug can shrink tumors. About 290 participants will take part in this early-phase trial.
Matched conditions: LOCALLY ADVANCED/METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Crescent Biopharma, Inc. • Aim: Disease control
Last updated May 22, 2026 14:04 UTC